Christina Fotopoulou
No ORCID on file
· 14 papers in corpus
· active 2009-2026
Study types
- article 3
- review 2
- other 1
Condition tags
- endometriosis 4
Top journals
Frequent coauthors
- Cooper N 4
- Da Silva A 3
- Madariaga A 3
- Cillian McNamara 2
- Ainhoa Madariaga 2
- Abrão MS 2
- Al-memar M 2
- Bradley J Monk 2
- Bogani G 2
- Amant F 2
article
2026
OBJECTIVE: To determine whether large language models (LLMs) can automatically extract organ-level disease involvement to populate the Surgical Findings section of the European Society of Gynaecological Oncology (ESGO) Operative Report for …
article
2026
review
2026
OBJECTIVE: To critically evaluate the evidence linking endometriosis to ovarian cancer, with particular focus on endometrioid and clear cell histologic subtypes, and to inform risk stratification and patient counseling. METHODS: A systemat…
2025
Ovarian cancer (OC) remains one of the leading causes of gynecologic cancer-related mortality, with most patients presenting with disseminated disease, particularly within the peritoneal cavity. Standard treatment includes cytoreductive sur…
other
2025
OBJECTIVE: To correlate the clinical history with imaging findings of women with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. DESIGN: Retrospective cohort study. SETTING: A UK IOTA and ESGO-certified tertiary referral centre for disord…
2023
IntroductionMany advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biological behavior data are now ava…
review
2023
Objective: to correlate the clinical history with imaging findings of women with MRKH Design: Retrospective cohort study Setting: A UK IOTA and ESGO-certified tertiary referral centre for disorders of reproductive development Population: Al…
2022
Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research.
Epithelial ovarian cancer (EOC) is a heterogenous disease associated with variations in presentation, pathology and prognosis. Advanced EOC is typified by frequent relapse and a historical 5-year survival of less than 30% despite improvemen…
2021
Gynaecological malignancies represent a heterogeneous group of neoplasms with vastly different aetiology, risk factors, molecular drivers, and disease outcomes. From HPV-driven cervical cancer where early screening and molecular diagnostics…
2021
The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group, and the European Society for Gynaecological Endosc…
2021
The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endosco…
2016
•Case describes a response to sunitinib in clear cell ovarian cancer.•Discussion of unique molecular characteristics of clear cell ovarian cancers•Practical points regarding dosing and toxicity when using sunitinib discussed.
2015
More than 25 years after the last revision, in 2012 the FIGO Oncology Committee began revising the FIGO classification for staging ovarian, Fallopian tube and primary peritoneal cancers. The new classification has become effective with its …
article
2009